Recent Press Releases

First-in-class type 2 diabetes treatment Glyxambi® (empagliflozin/linagliptin) tablets for adults now available in U.S. pharmacies

New dual inhibitor SGLT2/DPP-4 combination therapy offers improved glycemic control as an adjunct to diet and exercise

RIDGEFIELD, Conn.<

Serious and Life-Threatening Cases of Symptomatic Bradycardia as well as One Case of Fatal Cardiac Arrest Reported with Coadministration of amiodarone with either Harvoni® or with Sovaldi® in combination with another direct acting antiviral.

On March 20, 2015, FDA approved changes to the Harvoni (ledipasvir/sofosbuvir fixed dose combination) and Sovaldi (sofosbuvir) labels to update the WARNINGS AND PRECAUTIONS, ADVERSE REACTIONS, and...

EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals

HEMEL HEMPSTEAD, England, March 23, 2015 /PRNewswire via COMTEX/ -- HEMEL HEMPSTEAD, England, March 23, 2015 /PRNewswire/ -- EUSA Pharma (EUSA), a newly-established profitable specialty...

Biogen Idec Becomes Biogen

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its evolution...

Lilly and Innovent Biologics Announce a Strategic Alliance to Bring Potential Oncology Therapies to Patients in China and Around the World

Alliance Marks One of the Largest Biotech Drug Development Collaborations in China

BEIJING, March 20, 2015 /PRNewswire/ --&nb

Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals

Merkerson Visits Memphis, Tennessee on March 20 With America's Diabetes Challenge: Get to Your Goals Program

KENILWORTH, N.J.,

Amgen Submits Application For Investigational LDL Cholesterol-Lowering Medication Repatha™ (evolocumab) In Japan

Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma

THOUSAND OAKS, Cal

Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche

Provides Researchers with Global Access to Roche Biochemical Reagents Product Portfolio

ST.

Lilly and Hanmi Announce an Exclusive License and Collaboration Agreement for the Development and Commercialization of an Immunological Therapy

Development planned for multiple autoimmune diseases, including rheumatoid arthritis and lupus

INDIANAPOLIS,

GSK and Theravance Announce Outcome of US FDA Advisory Committee on BREO(R) ELLIPTA(R) in Asthma

GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the outcome of the joint meeting of the Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk...

SANOFI ANNOUNCES TOP-LINE RESULTS FOR CARDIOVASCULAR OUTCOMES STUDY OF LYXUMIA® (LIXISENATIDE)

- Results support resubmission of U.S. New Drug Application in Q3 2015 - Mar 19, 2015 PARIS, March 19, 2015 /PRNewswire/ -- Sanofi announced today top-line results of the Phase IIIb ELIXA...

ASTRAZENECA AND DAIICHI SANKYO TO JOINTLY COMMERCIALISE MOVANTIK IN THE US

AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc. for MOVANTIK™ (naloxegol) in the US, in line with the Company's strategy of delivering value through...

Help Protect Texas' Babies: Make sure your children are fully vaccinated

NEW YORK, March 18, 2015 /PRNewswire/ --  A new bilingual, online resource is now available for parents

Indian generic companies should reject Gilead's controversial hepatitis C 'Anti-Diversion' programme

Indian generic companies should reject Gilead's controversial hepatitis C 'Anti-Diversion' programme Programme could compromise patient treatment and privacy rights MSF releases briefing...

Johnson & Johnson Announces Strategic Investment Alliance to Combat Dementia Globally

NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced tha

Amgen To Present 10 Abstracts From Its Dermatology Portfolio At The 73rd Annual Meeting Of The American Academy Of Dermatology

Pivotal Results Comparing Brodalumab With Stelara® (Ustekinumab) and Placebo to be Presented in Late-Breaking Session

THOUSAND OAKS, Cali

Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

NEW BRUNSWICK, N.J., March 17, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference

Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States

FAVORABLE LATE-BREAKING CLINICAL TRIAL DATA FROM INITIAL COMMERCIAL USE PRESENTED ON TRANSCATHETER MITRAL VALVE REPAIR SYSTEM AT ACC 2015

Sandoz to Pay $12.64 Million in CMP Settlement with HHS OIG for Misrepresenting Drug Pricing Data to Medicare

Washington, DC - The HHS Office of Inspector General (OIG) announced today that Sandoz Inc. will pay $12.64 million to settle allegations it misrepresented drug pricing data to the Medicare program....

MD Anderson News Release: MD Anderson study predicts new hepatitis C drugs will place a dramatic financial strain on the health care system

HOUSTON ­­– The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country's...